VemiCo Company
veMico is developing a novel class of gut microbiome therapeutics based on Bifidobacterium spp. derived signalling molecules that play a key role in the regulation of systemic immune function.
Founded Date:
2018
Number Of Exists:
1-10
Industry:
Systemic
Headquarters:
Reading, Reading, United Kingdom